Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years

The European Respiratory Journal
Ganesh Raghu

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease. A major breakthrough in treatment came when, after decades of clinical trials which failed to identify an efficacious treatment regimen, two therapies were successful in Phase-III trials. The advent of these therapies, nintedanib and pirfenidone, meant that for the first time IPF patients had two treatment options that could reduce disease progression. This review summarises the key lessons to be obtained from the clinical trials that led to the current international clinical practice guidelines for the treatment of IPF and provides insights for the design of future clinical trials that are needed if we are to improve outcomes that are clinically meaningful to IPF patients.

References

Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·S ImokawaA Takada
Oct 2, 2002·Lancet·Hossein Ardeschir GhofraniFriedrich Grimminger
Jan 9, 2004·The New England Journal of Medicine·Ganesh RaghuUNKNOWN Idiopathic Pulmonary Fibrosis Study Group
Jan 25, 2005·American Journal of Respiratory and Critical Care Medicine·Arata AzumaShoji Kudoh
Sep 16, 2005·Chest·Hiroshi KuboHidetada Sasaki
Nov 25, 2005·The New England Journal of Medicine·Maurits DemedtsUNKNOWN IFIGENIA Study Group
Mar 24, 2007·American Journal of Respiratory Cell and Molecular Biology·Raksha JainBrigham C Willis
Sep 13, 2007·Experimental Lung Research·Kirsi VuorinenMarjukka Myllärniemi
Sep 29, 2007·American Journal of Respiratory and Critical Care Medicine·Talmadge E KingGanesh Raghu
Aug 2, 2008·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuSaeed Fatenejad
Dec 10, 2009·The European Respiratory Journal·H TaniguchiUNKNOWN Pirfenidone Clinical Study Group in Japan
Dec 17, 2009·American Journal of Respiratory and Critical Care Medicine·Craig E DanielsUNKNOWN Imatinib-IPF Study Investigators
May 21, 2010·The New England Journal of Medicine·UNKNOWN Idiopathic Pulmonary Fibrosis Clinical Research NetworkGary W Hunninghake
Oct 12, 2010·American Journal of Respiratory and Critical Care Medicine·Brett LeyTalmadge E King
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis
Apr 9, 2011·American Journal of Respiratory and Critical Care Medicine·Talmadge E KingJuergen Behr
May 17, 2011·Lancet·Paul W NobleUNKNOWN CAPACITY Study Group
Sep 24, 2011·American Journal of Respiratory and Critical Care Medicine·Roland M du BoisAthol U Wells
Oct 14, 2011·The New England Journal of Medicine·Luca RicheldiRoland M du Bois
May 9, 2012·American Journal of Respiratory and Critical Care Medicine·Imre NothUNKNOWN Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet)
May 23, 2012·The New England Journal of Medicine·UNKNOWN Idiopathic Pulmonary Fibrosis Clinical Research NetworkFernando J Martinez
Jun 26, 2012·Biochimica Et Biophysica Acta·Christian Beyer, Jörg H W Distler
Jul 17, 2012·American Journal of Respiratory and Critical Care Medicine·Roland M du BoisPaul W Noble
May 8, 2013·Annals of Internal Medicine·Ganesh RaghuUNKNOWN ARTEMIS-IPF Investigators*
May 18, 2013·The European Respiratory Journal·Ganesh RaghuUNKNOWN MUSIC Study Group
Nov 2, 2013·The European Respiratory Journal·Jason W ChienThomas O'Riordan
Feb 22, 2014·The Journal of Pharmacology and Experimental Therapeutics·Lutz WollinBernhard Ryffel
Mar 5, 2014·European Respiratory Review : an Official Journal of the European Respiratory Society·Vincent Cottin, Luca Richeldi
May 20, 2014·The New England Journal of Medicine·Fernando J MartinezGanesh Raghu
May 20, 2014·The New England Journal of Medicine·Luca RicheldiUNKNOWN INPULSIS Trial Investigators
May 20, 2014·The New England Journal of Medicine·Talmadge E KingUNKNOWN ASCEND Study Group
Mar 7, 2015·The European Respiratory Journal·Lutz WollinMartin Kolb
Mar 26, 2015·The New England Journal of Medicine·Banu A Karimi-Shah, Badrul A Chowdhury
Jul 16, 2015·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN Latin American Thoracic Association
Sep 4, 2015·American Journal of Respiratory and Critical Care Medicine·Justin M OldhamUNKNOWN IPFnet Investigators
Sep 24, 2015·American Journal of Respiratory and Critical Care Medicine·Ulrich CostabelArata Azuma
Oct 2, 2015·The European Respiratory Journal·Ganesh RaghuSusanne Stowasser

❮ Previous
Next ❯

Citations

Aug 8, 2018·European Journal of Heart Failure·Francesca GrazianiLuca Richeldi
Sep 22, 2018·Current Opinion in Rheumatology·Laure GallayBaptiste Hervier
Dec 5, 2018·Expert Opinion on Investigational Drugs·Seidai SatoMartin R J Kolb
Jan 16, 2019·Cell Death and Differentiation·Yingzhun ChenHaihai Liang
Dec 14, 2018·The European Respiratory Journal·Marlies S WijsenbeekVincent Cottin
Jul 7, 2018·The European Respiratory Journal·Pierre-Simon BellayeMartin Kolb
Jan 20, 2018·The European Respiratory Journal·Christopher J Ryerson, Martin Kolb
Feb 23, 2018·The European Respiratory Journal·François VincentStéphane Gaudry
Feb 14, 2018·The European Respiratory Journal·Philippe BonniaudCarmen Garrido
Nov 18, 2018·The European Respiratory Journal·Luca RicheldiToby M Maher
Dec 24, 2018·The European Respiratory Journal·Nasreen KhalilMartin Kolb
Feb 14, 2019·American Journal of Physiology. Lung Cellular and Molecular Physiology·Subhendu MukherjeeLuke J Janssen
Jul 10, 2019·The Annals of Pharmacotherapy·Roy Pleasants, Robert M Tighe
Dec 17, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Francesco VaroneLuca Richeldi
Jun 5, 2019·American Journal of Respiratory Cell and Molecular Biology·Yu WangQun Yu
Jan 23, 2020·American Journal of Respiratory Cell and Molecular Biology·Saleela M RuwanpuraPhilip G Bardin
Sep 8, 2019·Respiratory Research·Toby M Maher, Mary E Strek
Sep 6, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Vivien SomogyiMichael Kreuter
Mar 16, 2019·Respiratory Research·Martin Kolb, Martina Vašáková
Oct 4, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Bridget F Collins, Ganesh Raghu
Apr 30, 2019·American Journal of Respiratory and Critical Care Medicine·Daniel A CulverHyun J Kim
Aug 8, 2020·EMBO Molecular Medicine·Rajesh K KasamSatish K Madala
Jul 23, 2020·Yeungnam University Journal of Medicine·Suji KimChang-Hoon Woo
Aug 5, 2020·American Journal of Respiratory and Critical Care Medicine·Anne E HollandNatasha Smallwood
Jan 7, 2021·The European Respiratory Journal·Anna J PodolanczukGanesh Raghu
Jan 3, 2021·Free Radical Biology & Medicine·Linhui LiChing-Hsien Chen
Feb 2, 2019·Respiratory Medicine·P HeukelsM Kool
Jan 14, 2021·Seminars in Arthritis and Rheumatism·B WuM Kapoor
Oct 28, 2020·The Indian Journal of Medical Research·Vijay Hadda, Randeep Guleria
Jun 17, 2021·Scandinavian Journal of Rheumatology·S OttavianiB Crestani
Jun 28, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Haipeng ChengZiqiang Luo
Mar 25, 2021·American Journal of Respiratory Cell and Molecular Biology·Ping ZhangChuanyue Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Respiratory Review : an Official Journal of the European Respiratory Society
Ganesh Raghu
Archivos de bronconeumología
Esteban Cano-Jiménez
© 2022 Meta ULC. All rights reserved